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Replication-dependent histone mRNAs are the only eukaryotic cellular mRNAs that are not polyadenylated,
ending instead in a conserved stem-loop. The 3 end of histone mRNA is required for histone mRNA trans-
lation, as is the stem-loop binding protein (SLBP), which binds the 3 end of histone mRNA. We have identified
five conserved residues in a 15-amino-acid region in the amino-terminal portion of SLBP, each of which is
required for translation. Using a yeast two-hybrid screen, we identified a novel protein, SLBP-interacting
protein 1 (SLIP1), that specifically interacts with this region. Mutations in any of the residues required for
translation reduces SLIP1 binding to SLBP. The expression of SLIP1 in Xenopus oocytes together with human
SLBP stimulates translation of a reporter mRNA ending in the stem-loop but not a reporter with a poly(A) tail.
The expression of SLIP1 in HeLa cells also stimulates the expression of a green fluorescent protein reporter
mRNA ending in a stem-loop. RNA interference-mediated downregulation of endogenous SLIP1 reduces the
rate of translation of endogenous histone mRNA and also reduces cell viability. SLIP1 may function by
bridging the 3 end of the histone mRNA with the 5 end of the mRNA, similar to the mechanism of translation
of polyadenylated mRNAs.
Metazoan replication-dependent histone mRNAs differ
from other eukaryotic mRNAs in that they do not end in
poly(A) tails. Instead, these mRNAs end in a conserved 26-
nucleotide sequence that contains a stem-loop (3). The stem-
loop binding protein (SLBP) binds to the stem-loop and is
required for both histone pre-mRNA processing in the nucleus
(4, 9, 26) and histone mRNA translation in the cytoplasm (7,
24). The efficient translation of polyadenylated mRNAs re-
quires both the cap and the poly(A) tail (5). The role of the
poly(A) tail in translation in both mammals and yeast (Sac-
charomyces cerevisiae) is well understood. The 5 mRNA cap is
bound by eukaryotic initiation factor 4E (eIF4E), which inter-
acts with the large scaffold protein eIF4G. In mammals, the
poly(A) tail is bound by PABP in the cytoplasm, and PABP
also interacts directly with eIF4G (8). Direct biochemical ex-
periments using purified yeast PABP, eIF4E, and eIF4G dem-
onstrate that these three factors can effectively circularize the
mRNA (34), and this structure is thought to both stabilize the
mRNA and enhance the recycling of terminating ribosomes,
thus increasing translation efficiency.
PABP can also interact with other factors, including PAIP1
(2) and PAIP2 (13), which act to stimulate and inhibit trans-
lation, respectively. PAIP1 and PAIP2 compete for the same
site in the C-terminal region of PABP (13, 23), a site distinct
from the binding site on PABP for eIF4G (12). The binding of
the PAIP proteins to PABP acts to increase or decrease its
affinity for eIF4G. When bound with PAIP2, PABP does not
interact as strongly with eIF4G (10, 13), while PAIP1 bound to
PABP stimulates the formation of the translation initiation
complex.
Histone mRNAs, although they have a different 3 end, may
be translated by a similar mechanism as the “standard” poly-
adenylated mRNAs. In support of this possibility, the transla-
tion of histone mRNA in mammalian cells also requires both
the cap and the stem-loop (6). Histone mRNA translation is
uniquely regulated during oogenesis in Xenopus laevis. Inter-
estingly, histone mRNAs with an oligo(A) tail added to the
stem-loop are stored in a translationally inactive particle until
oocyte maturation (1, 36). There are two SLBPs in Xenopus
oocytes: xSLBP1, the orthologue of the mammalian SLBP, and
xSLBP2, which is oocyte specific (32). There are no identified
orthologues of xSLBP2 in mammals. Previous studies demon-
strated that xSLBP1 is required for the efficient translation of
histone mRNA and that xSLBP2 inhibits histone mRNA trans-
lation (24). xSLBP2 is bound to the stored translationally in-
active histone mRNA in stage VI oocytes and is degraded
during oocyte maturation, allowing the activation of transla-
tion by xSLBP1 (25, 32).
SLBP stimulates the translation of histone mRNA in Xeno-
pus oocytes (7, 24) and in reticulocyte lysates (24). We identi-
fied a 15-amino-acid (aa) region in the amino-terminal domain
of xSLBP1 (aa 68 to 83) which is essential for the activation of
histone mRNA translation (24). Deletion or mutation of this
sequence completely abolished the activity of xSLBP1 in trans-
lation. A region of xSLBP1 containing this sequence fused to
xSLBP2 converted xSLBP2 to an activator, and an MS2-
xSLBP1 or MS2-human SLBP (hSLBP) fusion protein activated
the translation of a reporter mRNA ending in an MS2 site,
indicating that the RNA binding domain (RBD) of xSLBP1
was not required for translation (7, 24).
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Here we further characterize the specific sequences in SLBP
required for translation and report the isolation of a protein,
SLIP1 (SLBP-interacting protein 1), which specifically binds to
the translation activation region of SLBP. We demonstrate
that SLIP1, together with xSLBP1 or hSLBP, activates the
translation of mRNAs ending in the histone stem-loop both in
Xenopus oocytes and in mammalian cells. Further supporting a
role for SLIP1 in translation, we find that SLIP1 interacts with
eIF4GI and eIF4GII. We propose that SLIP1 stimulates his-
tone mRNA translation by bridging between SLBP and the 5
end of histone mRNA.
MATERIALS AND METHODS
Plasmid constructions. Wild-type xSLBP1, xSLBP2, and hSLBP were cloned
into the modified p64T vector pXFRM as previously described (32). Single or
double amino acid substitutions to alanine were generated by site-directed mu-
tagenesis. The xSLBP1 internal deletions xSLBP189-126 and xSLBP1112-126
were generated by PCR. The chimeric mutant xSLBP1-(x2 89-126) was gener-
ated by deletion of 37 aa (aa 89 to 126) from xSLBP1 and insertion of 35 aa of
xSLBP2 (aa 90 to 125) into the matching location. xSLBP 1-89-xSLBP2 has the
first 89 aa of xSLBP1 fused to xSLBP2 starting at aa 90.
For directed yeast two-hybrid assays, xSLBP1 or indicated mutants were
cloned into the pGBT8 vector by use of PCR, and hSLIP1 was cloned into
pGAD10. Luc-poly(A), Luc-SL, Luc-TL, Luc-MS2, and CAT-A50 constructs
have been previously described (6, 24).
hSLIP1 was cloned into the pGEX vector to generate GST-hSLIP1. Hemag-
glutinin (HA)-hSLIP1 was generated by cloning hSLIP1 into pcDNA3. To gen-
erate the siRNA1-resistant form of HA-hSLIP1 in pcDNA3.HA, we used prim-
ers to introduce conserved changes in the third bases of the five codons targeted
by the small interfering RNA (siRNA).
In vitro transcription. Luc-SL, Luc-TL, Luc-poly(A), Luc-MS2, and CAT-A50
were transcribed with T7 RNA polymerase in the presence (for experiments in
oocytes) or the absence (for experiments in reticulocyte lysate) of a cap analogue
as previously described (24). The clones encoding SLBPs and SLIP1 proteins
from pXFRM (32) were linearized with EcoRI and transcribed with SP6 poly-
merase in the presence of a cap analogue.
In vitro translation. SLBP, hSLIP1, eIF4GI, and eIF4GII were expressed in a
reticulocyte lysate as described previously (24). One-third of the in vitro trans-
lation reactions were resolved by sodium dodecyl sulfate (SDS)-12% polyacryl-
amide gel electrophoresis (PAGE), and protein synthesis detected using a Storm
840 PhosphorImager. The remainder was used for the glutathione S-transferase
(GST) pulldown experiments. hSLBP, hSLIP1, and MS2 viral coat proteins were
expressed in reticulocyte lysate, and 1/20 of the reaction mixture was used for
Western blot analysis against SLIP1 protein.
In vivo translation assay. In vivo injection experiments and measurements of
firefly luciferase activities in Xenopus oocytes were performed as described pre-
viously (24). The results were normalized to the expression of Luc-TL, which was
set at 1. When Luc-poly(A) and Luc-SL mRNAs activities in Xenopus oocytes
were compared, their activities were normalized to the amount of luciferase
expressed in oocytes injected with buffer. RNA was isolated from oocytes by use
of Trizol reagent (Invitrogen) as per the manufacturer’s instructions. One oocyte
equivalent of RNA was electrophoresed on a denaturing formaldehyde agarose
gel and probed with a purified NcoI/XbaI-digested fragment of the Luc-SL
plasmid containing the full-length firefly luciferase open reading frame.
Western blot analysis. Proteins were extracted from oocytes as previously
described (24). Proteins from HeLa cell lysates extracted in NP-40 lysis buffer (50
mM Tris-Cl [pH 7.5], 150 mM NaCl, 0.5% NP-40, 50 mM NaF, 1 mM phenyl-
methylsulfonyl fluoride, 1 mM dithiothreitol, 1 protease inhibitor cocktail
[P8340; Sigma]) were used for Western blot analysis. Transfected or untrans-
fected CG-1945 yeast cells were grown in yeast-peptone-dextrose medium to an
optical density at 595 nm of 1.0 at 27°C, and protein extracts were analyzed on
12% SDS-PAGE gels and by Western blotting. A polyclonal antibody was gen-
erated in rabbits against full-length hSLIP1 as a GST fusion protein, and a
second polyclonal antibody was generated in rabbit against a peptide containing
the C terminus of hSLIP1 (CTPAAHKYYYSEVSD) (Pacific Immunology).
Dilutions of antibodies used for Western blotting were as follows: rabbit poly-
clonal anti-xSLBP1 (32), rabbit polyclonal anti-hSLBP (33), rabbit polyclonal
anti-hSLIP1 (full length), 1:500; rabbit polyclonal anti-hSLIP1 (C terminal),
1:1,000; mouse monoclonal anti-caspase 9 (MBL International), 1:1,000; rabbit
polyclonal anti-eIF4GI (gift from Robert Rhoads, Louisiana State University
Health Sciences Center); rabbit polyclonal anti-PTB (polypyrimidine tract bind-
ing protein), 1:2,000 (gift from Mariano Garcia-Blanco, Duke University); mouse
monoclonal anti-HA, 1:1,000 (Covance); and horseradish peroxidase-conjugated
anti-rabbit or anti-mouse immunoglobulin G, 1:10,000 (GE Healthcare).
Directed yeast two-hybrid experiments. The CG-1945 yeast strain was trans-
formed with the pGBT8 bait plasmids encoding SLBPs under TRP1 selection and
then with target plasmid pGAD10 bearing hSLIP1 (Leu). The cells were grown
on medium lacking leucine and tryptophan. Four individual colonies for each
interaction were plated on SD minimal medium lacking tryptophan, leucine, and
histidine and containing 20 mM of 3-aminotriazole (33). The same colonies
tested for the interaction were also analyzed for protein expression by Western
blotting.
Immunoprecipitation. HeLa cells stably expressing HA-hSLIP1 were grown to
70 to 80% confluence on 150-mm plates containing Dulbecco’s modified Eagle
medium (DMEM) including 10% fetal bovine serum and 1% Geneticin. Six
plates were used for each experiment. In some experiments, cells were treated
with 5 mM hydroxyurea (HU) 1 h prior to lysis. Cells were lysed on ice for 15 min
in NP-40 lysis buffer and clarified by centrifugation at 15,000  g for 10 min.
Lysates were then incubated with either anti-HA (Covance) or anti-myc (Invitro-
gen) for 2 h at 4°C. Protein G beads were equilibrated with phosphate-buffered
saline (PBS) including 0.07% NP-40 and resuspended in an equal volume of PBS.
Fifty microliters of protein G beads was added to lysates and incubated for 1 h
at 4°C. The beads were washed with lysis buffer and resuspended in 2 SDS
sample buffer, and the proteins were detected by Western blotting. RNase
treatment was carried out either by adding 10 g/ml RNase A to the lysates prior
to immunoprecipitation (11) or by treating the protein G beads with RNase after
immunoprecipitation. Identical results were obtained with each approach.
Transfection with siRNAs and measurement of cell growth. Two siRNAs,
siRNA1 (UUAUACUCCUCUCUACUGGdTdT) and siRNA2 (AUGAUGGC
GUAGCACAUGCdTdT) for hSLIP1 (lowercase letters indicate deoxynucleoti-
des), were purchased from Dharmacon, Inc. The control siRNA C2 and hSLBP
siRNA were previously described (29). Cells were harvested 48 h after transfec-
tion. Levels of the proteins were determined by Western blot analysis. For
growth analysis, 2.5  105 HeLa cells/well in a six-well plate were cotransfected
with the combinations of 180 nM control siRNA or HA-hSLIP1 siRNA and 500
ng of siRNA-resistant forms of HA-hSLIP1 or green fluorescent protein (GFP)
expression constructs. Transfections were performed with Lipofectamine Regu-
lar (Life Tech) according to the manufacturer’s instructions. At 24, 48, and 72 h
posttransfection, cells were collected and viabilities determined by trypan blue
exclusion. Cell cycle analysis of siRNA-treated cells was determined by pro-
pidium iodide staining followed by flow cytometry as previously described (29).
Cell culture and transient transfection. Culturing 293T cells and transfection
of cDNAs were carried out as described previously (28). Cell lines expressing
HA-hSLIP1 were isolated by first transfecting cells with HA-hSLIP1 cloned in
pcDNA3, and a stable population of cells resistant to G418 was selected. The
cells were plated at low density and clones were isolated. These clones were
expanded and the cells expressing HA-hSLIP1 were identified by Western blot-
ting and immunofluorescence, and cultures with 100% of the cells expressing
SLIP1 were utilized in the experiments. Apoptosis was induced in HeLa cells
through a 6-h treatment of cells with 1 M staurosporine, while cells treated with
an equivalent volume of dimethyl sulfoxide served as a negative control.
Protein expression and purification. Expression of hSLBP-His, GST-hSLBP-
His, GST-hSLBP1-68-His, GST-hSLBP1-81-His, and GST-hSLBP1-126-His
in Sf9 insect cells was previously described (9), and these were purified as
described previously (4).
GST-fused hSLIP1 proteins were expressed from pGEX vector in
BL21(DE3) cells. The proteins were purified from a clarified cell lysate incu-
bated for 2 h at 4°C with 1 ml of a slurry of glutathione-Sepharose beads
equilibrated with lysis buffer per liter of culture. Proteins were eluted with 5 mM
glutathione (G4251; Sigma) and were quantified by SDS-PAGE using Coomassie
staining or a Bio-Rad assay with bovine serum albumin as a standard.
GST pulldown assay. Five to 10 micrograms of Escherichia coli-expressed
GST-hSLIP1 was incubated with 5 to 8 l [35S]methionine-labeled SLBP pro-
teins on ice for 30 min. Protein mixtures were then added with 50 l (50%
[vol/vol]) glutathione 4B Sepharose beads (Amersham) equilibrated in PBS and
incubated for an additional 30 min on ice. Beads were washed three times with
PBS supplemented with 200 mM NaCl. Proteins bound to beads were recovered
in 40 l 2 SDS sample buffer. Reciprocal experiments were performed with the
same strategy as described above, in which baculovirus-expressed GST-hSLBP
and its mutants were utilized to pull down hSLIP1 labeled with [35S]methionine.
The GST proteins were isolated on glutathione beads, and the proteins were
solubilized by boiling in sample buffer and then resolved by SDS-PAGE. The gel
was dried and the proteins were detected by autoradiography or with a
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PhosphorImager. The direct pulldown of baculovirus-expressed His-hSLBP by
GST-hSLIP1 was analyzed by Western blotting.
Pulldowns of [35S]methionine-labeled eIF4GI, eIF4GII, and their fragments
were performed with GST-hSLIP1 as described above. The GST proteins were
isolated on glutathione beads, and the proteins solubilized by boiling in sample
buffer and then resolved by SDS-PAGE. The gel was dried and the proteins were
detected by autoradiography or with a PhosphorImager.
Expression of the GFP-SL reporter. 293T cells were transfected with plasmids
encoding either LacZ (control) or myc-tagged ZFP100 (28) by use of Lipo-
fectamine 2000 (Invitrogen, CA) according to the manufacturer’s protocols. The
following day, 2 g of GFP-SL reporter (31) was cotransfected with increasing
amounts of plasmid encoding hSLIP1 and decreasing amounts of plasmid en-
coding LacZ by use of Lipofectamine reagent (Invitrogen, CA). Note that there
was a total of 4 g of plasmid present in all transfections, thus allowing for
equivalent transfection efficiencies. Two days after the second transfection, cells
were harvested and measured by fluorescence-activated cell sorter (FACS) anal-
ysis and analyzed using Summit software (Fort Collins, CO). Total cell RNA was
analyzed for reporter mRNA with an S1 nuclease protection assay (31) or using
a Northern blot analysis of cellular RNA (2 g) that was separated by electro-
phoresis using a 6% denaturing acrylamide gel.
Pulse-labeling of cellular proteins. HeLa cells were transfected with siRNAs
as described above. Following the siRNA treatment for 72 h, cells were starved
for methionine for 30 min at 37°C in DMEM starvation medium (DMEM lacking
methionine and supplemented with 1 mM sodium pyruvate, 0.25 mM HEPES
[pH 7.3], and 2 mM L-glutamine). Cells were then exchanged into starvation
medium supplemented with [35S]methionine at 10 l/ml (0.1 mCi/ml) and la-
beled for 10 min at 37°C. Cells were washed three times with cold 1 PBS,
scraped into 1 PBS, and pelleted at 2,000 rpm for 5 min at 4°C. The cell pellet
was lysed in a nuclear isolation buffer (250 mM sucrose, 1 mM CaCl2, 2 mM
MgCl2, 1% Triton X-100, 10 mM Tris-HCl [pH 8], and 2 mM phenylmethylsul-
fonyl fluoride) for 60 min on ice. Nuclei were pelleted at 5,000 rpm for 5 min at
4°C. The nuclear pellet was resuspended in 0.4 N HCl and incubated on ice for
30 min. Nuclear samples were centrifuged at 15,000 rpm for 15 min at 4°C and
acid-soluble proteins precipitated in 20% trichloroacetic acid at 20°C over-
night. Samples were then centrifuged at 15,000 rpm for 30 min at 4°C. Protein
pellets were washed three times with cold acetone, dried, and resuspended in
sample buffer for SDS-PAGE analysis and autoradiography.
RESULTS
The region between aa 85 and the RBD is not required for
translation. Our initial experiments had defined a 15-aa region
of xSLBP1 (aa 68 to 83) required for translation and demon-
strated that the amino-terminal 68 aa and C-terminal 57 aa
were not essential for translation (24). Using an MS2-SLBP
fusion protein, Gorgoni and coworkers demonstrated that aa 1
to 127 fused to MS2 had the same stimulatory activity on
histone mRNA translation as the full-length protein (7). We
had not tested whether there might also be a role for aa 83 to
126, located between the translation activation region and the
start of the RBD. We created mutants in SLBP to address
whether this region also plays a role in translation using Xen-
opus oocytes.
The assay used to measure the activity of the stem-loop
reporters (24) is diagrammed in Fig. 1A. Control oocytes were
injected with buffer or with mRNA encoding xSLBP2, which is
inactive in translation. Briefly, oocytes were injected with syn-
thetic capped mRNAs encoding the proteins of interest, incu-
bated for 16 h to allow protein expression, and then injected
with the reporter mRNAs, luciferase mRNAs ending in either
a stem-loop (Luc-SL) or a tetraloop which does not bind SLBP
(Luc-TL), or a poly(A) tail [Luc-poly(A)]. Sixteen hours later,
the oocytes were harvested and the luciferase activity was mea-
sured. The activity of the Luc-TL was used as a control, and its
activity was set at 1. The levels of the expressed proteins were
determined by Western blotting. Note that there is some
xSLBP1 in the oocyte, and thus oocytes injected with buffer
show a small activation of translation of the Luc-SL reporter
(24) (Fig. 1C).
To determine whether the region between the translation
activation domain and the RBD of SLBP is required for trans-
lation, we created the SLBP mutants shown in Fig. 1B. We
deleted the region between aa 112 and 126 (xSLBP1112-126)
and also that between 89 and 126 (xSLBP189-126). We re-
placed aa 1 to 88 of xSLBP2 with the same region of xSLBP1
(xSLBP1 1-89-xSLBP2), which resulted in a fusion protein that
contained just the first 89 aa from xSLBP1. We then deleted
the region between aa 89 and the RBD in this clone to give
xSLBP289-126 (x1 1-89). To determine whether a specific
sequence was required at positions 89 to 126, we replaced aa 89
to 126 of xSLBP1 with those from xSLBP2 [xSLBP1-(x2 89-
126)].
Deletion of the 37 aa from 89 to 126 (xSLBP189-126)
abolished translation activation activity in Xenopus oocytes,
while deletion of only 14 aa (the serine-rich linker region) from
112 to 126 (xSLBP1112-126) had no effect on translation
(Fig. 1C). However, when the 37 aa from xSLBP2 were sub-
stituted for aa 89 to 126 of xSLBP1 [xSLBP1-(x2 89-126)], the
resulting protein had complete activity, even though there is no
similarity between xSLBP1 and xSLBP2 in this region. This
result demonstrates that the effect of the deletion is likely to
alter the spacing between the translation activation region and
the RBD and that specific sequences in this region are not
required for translation. Similarly, a protein that contains only
the first 89 aa of xSLBP1 followed by the remainder of the
xSLBP2 protein (xSLBP1 1-89-xSLBP2) had full activity in
translation (Fig. 1C), while a protein that has aa 89 to 126
deleted from this protein [xSLBP289-126 (x1 1-89)] was in-
active. All of these proteins were overexpressed in the oo-
cytes as assayed by Western blotting using xSLBP1 antibody
(Fig. 1D).
These results demonstrate that specific sequences in xSLBP1
between aa 83 and 126 were not required for translation, but
an appropriate spacing between the RBD and the translation
activation region was important for translation activation.
Since we have previously shown that the removal of the first 67
aa of xSLBP1 and the entire C-terminal domain has no effect
on translation activity (24), we conclude that the only essential
region for translation lies between aa 68 and 83.
Identification of critical residues in the translation activa-
tion region of SLBP. Comparison of the SLBP sequences from
vertebrates reveals that there is extensive conservation of much
of the SLBP sequence throughout the protein (33). However,
when we included sea urchin (22) and Ciona intestinalis (sea
squirt) in the comparison, then the similarity among the SLBPs
is only in the RBD and the region we identified as important
for translation. The sequences in this region for human, Xeno-
pus, sea urchin, and Ciona are compared in Fig. 2A. Extending
the comparison to more evolutionarily distant organisms (Dro-
sophila melanogaster and Caenorhabditis elegans) results in a
loss of obvious similarity among the SLBPs other than in the
RBD, and the Drosophila SLBP is not active in translation in
Xenopus oocytes (Sanchez and Marzluff, unpublished). The
sequence comparison suggested that a consensus core se-
quence required for translation might be DWX3VEE, with the
invariant amino acids underlined.
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Based on this analysis, we made a number of point mutants
in the consensus sequence in xSLBP1 and tested them for
activity in translation. We assayed the ability of the mutant
xSLBP1s to enhance translation of a luciferase reporter
mRNA ending with a histone stem-loop in Xenopus oocytes
(24) by use of the experimental system shown in Fig. 1A.
Synthetic mRNAs encoding xSLBP1 mutants were injected
into stage VI oocytes to express the SLBP. Control oocytes
were injected with buffer or with mRNA encoding xSLBP2,
which binds the stem-loop but is inactive in translation. Oo-
cytes were then injected with the Luc-SL or Luc-TL reporter
mRNA and 16 h later assayed for luciferase activity (Fig. 2B).
The expression of all the proteins was monitored by Western
blotting (Fig. 2C).
Point mutations in the conserved residues reduced activity of
xSLBP1 in this assay (Fig. 2B). Mutation of aspartic acid to
alanine (D72A), tryptophan to phenylalanine or alanine
(W73F and W73A), valine to glycine or alanine (V77G and
V77A), or glutamic acid to alanines (E78A, E79A, and
EE7879AA) abolished the translation stimulation activity of
SLBP. In contrast, mutation of the nonconserved amino acids
glycine and serine to alanines (GS7475AA) did not affect the
ability of SLBP to enhance translation of the stem-loop re-
porter mRNA. These results demonstrate that each of the
conserved amino acids is essential in this system. All of the
mutant proteins were expressed in excess of endogenous
xSLBP1 in Xenopus oocytes (Fig. 2C), although the D72A and
V77A mutants were expressed at lower levels than the other
proteins.
Identification of a factor that binds the region of SLBP
required for translation activation. We performed a yeast two-
hybrid screen with hSLBP lacking the last 27 aa as the bait (the
FIG. 1. Analysis of activity of deletion mutants of xSLBP1 in Xenopus oocytes. (A) Schematic of Xenopus oocyte system used as an in vivo
translation assay (24). The structures of the luciferase reporters Luc-SL, Luc-TL, and Luc-poly(A) are shown. Abbreviations: ORF, open reading
frame; UTR, untranslated region. (B) The structure of the mutant proteins. The central domain of the xSLBPs contains the RBD, beginning with
amino acid 126, and the translation activation domain of xSLBP1 is indicated (amino acids 68 to 83). (C) Synthetic mRNAs encoding each of these
proteins were injected into Xenopus oocytes, and 16 h later the Luc-SL or Luc-TL mRNAs were injected. Sixteen hours later, the oocytes were
harvested and luciferase activity was measured. Results are normalized to the Luc-TL activity. (D) The levels of the expressed proteins in the
experiment shown in panel C were analyzed by Western blotting using anti-xSLBP1 antibody (which cross-reacts weakly with xSLBP2 (lanes 13
and 14) to demonstrate the expression of the mutant proteins.
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last 27 aa contains an intrinsic trans-activation activity), against
a HeLa cell cDNA library. One of the clones isolated, hSLIP1,
encoded a 222-aa protein that has not previously been func-
tionally characterized (Fig. 3A). Comparing this clone with the
expressed sequence tag (EST) database as well as the mouse
genome and EST databases suggested that it encoded a full-
length polypeptide plus an extensive portion of the 5 untrans-
lated region which remained in frame with the initiator AUG.
An antibody prepared to the C-terminal peptide of hSLIP1
interacts with a single polypeptide in HeLa cells, which is
identical in mobility to the polypeptide produced from the
cloned SLIP1 in reticulocyte lysates (Fig. 3B). Although there
are potential alternative spliced forms of SLIP1 in the EST
databases, we have no evidence for any alternatively spliced
forms of SLIP1 expressed in significant amounts (Fig. 3B). The
sequence of SLIP1 (Fig. 3A) is most similar to a number of
translation factors. The structure of the zebrafish orthologue of
SLIP1 has recently been determined in a structure genomics
project (PDB 2I2OA and 2I2OB), and the protein contains a
number of HEAT repeats which are similar to those found in
the middle domain of eIF4G and CBP80 (17, 18).
We confirmed the interaction of SLBP and SLIP1 and
mapped the region of SLIP1 and SLBP that interact both by
directed yeast two-hybrid experiments and by in vitro binding
experiments using GST pulldown assays. xSLBP1 interacts
with hSLIP1 in a yeast two-hybrid assay (Fig. 3C). A mutant of
xSLBP1 which has aa 68 to 123 deleted (xSLBP168-123),
including the region from 68 to 83 required for translation, did
not interact with hSLIP1. Similarly, xSLBP1W73A, which con-
tains a point mutation in the conserved tryptophan 73 critical
for xSLBP1 function in translation, also did not interact with
hSLIP1, although the deletion and mutant proteins were ex-
pressed at levels similar to those seen for the wild-type protein
(Fig. 3C, lanes 2 to 4).
We tested the ability of GST-hSLIP1 expressed in E. coli to
pull down 35S-labeled xSLBP1 labeled by in vitro translation.
The xSLBP1 bound to GST-hSLIP1 (Fig. 3D, lane 3). Binding
of the D72A, W73A, E78A, and EE7879AA mutants of
xSLBP1 to hSLIP1 was much lower than seen for the wild type
and similar to binding to the GST control (Fig. 3D, lanes 6, 9,
18, and 24), and the W73F mutant bound less strongly than
wild-type xSLBP1 (Fig. 3D, lane 12). The GS7475AA and
E79A mutants bound with efficiencies similar to that of wild-
type xSLBP1 in this assay (Fig. 3D, lanes 15 and 21). These
results are in agreement with the directed yeast two-hybrid
data.
GST fusion proteins containing various N-terminal deletions
of hSLBP were used in a reciprocal GST pulldown assay with
35S-labeled hSLIP1 (Fig. 3E). Both the full-length hSLBP and
the hSLBP1-68 protein bound hSLIP1 with equal efficiency
(Fig. 3E, lanes 2 and 3), while hSLBP1-81 and hSLBP1-126,
which have the entire translation activation domain deleted,
bound very weakly to hSLIP1 (Fig. 3E, lanes 4 and 5). Purified
recombinant His-tagged hSLBP also interacted with purified
recombinant GST-hSLIP1 in vitro, demonstrating that there
was no dependence on other proteins or RNAs for this inter-
action (Fig. 3F).
hSLIP1 cooperates with SLBP to stimulate translation of a
reporter mRNA ending in the histone stem-loop in Xenopus
oocytes. To test whether hSLIP1 plays a role in the translation
of histone mRNAs, we injected synthetic mRNAs encoding
xSLBP1, hSLBP, or hSLIP1 and we compared the effect of
expressing SLBP with the effect of coexpressing SLBP and
hSLIP1 on the activation of the Luc-SL reporter. xSLBP1
stimulated expression of the Luc-SL more than hSLBP did, as
previously reported (7, 24). The expression of hSLIP1 alone
had little effect on the expression of the Luc-SL reporter (Fig.
4A and B), suggesting that in the presence of limiting amounts
of xSLBP1 in the oocyte, xSLIP1 is not limiting. However, the
expression of hSLIP1 together with xSLBP1 resulted in an
additional 1.5- to 2-fold increase in total activity (Fig. 4A and
B). Moreover, the expression of hSLIP1 together with hSLBP
also resulted in an increase in activity, up to the same level as
seen for xSLBP1, with hSLIP1 (Fig. 4A).
We further tested the effect of SLIP1 on the translation of a
FIG. 2. Identification of amino acids in the translation activation
region of SLBP required for activity. (A) The sequences of xSLBP1,
hSLBP, sea urchin SLBP (suSLBP), and Ciona SLBP (cSLBP) are
compared in the region just before the RBD. The numbering is for
xSLBP1. The thickly underlined region(s) within 72 to 79 is the con-
sensus core translation activation region, and the thinly underlined
region from 95 to 99 is the cyclin binding site required for SLBP
degradation (38). (B) Wild-type xSLBP1, xSLBP2, or the indicated
mutants of xSLBP1 were expressed in Xenopus oocytes by injection of
synthetic capped mRNA as described in Fig. 1A. Results are expressed
relative to the expression of the Luc-TL mRNA, which was set at 1.
Oocytes injected with buffer served as a control. They have activity
higher than 1 because of the endogenous xSLBP1 in the oocyte. For
each point, 12 oocytes were pooled. The results are an average of three
independent experiments using oocytes from different frogs. (C) Pro-
tein from the equivalent of 0.5 oocyte that had been injected with
either Luc-SL or Luc-TL reporter in Fig. 2B was resolved on 12%
SDS-PAGE. The amounts of wild-type xSLBP1 and xSLBP1 mutants
were determined by Western blot analysis.
1186 CAKMAKCI ET AL. MOL. CELL. BIOL.
polyadenylated luciferase reporter mRNA [Luc-poly(A)].
While the expression of hSLIP1 together with xSLBP1 stimu-
lated the translation of Luc-SL compared with what was seen
for injection of xSLBP1 alone, hSLIP1 had no effect on the
translation of the Luc-poly(A) mRNA (Fig. 4B). Thus, the
effect of SLIP1 is specific for the Luc-SL mRNA.
Western blots confirmed that the hSLIP1 (Fig. 4C) and
SLBP (Fig. 4D) proteins were expressed in the oocytes and
that protein levels were not affected by the injection of re-
porter mRNAs or the injection of multiple mRNAs. We inter-
pret the low activity level of hSLBP in oocytes compared to
that seen for xSLBP1 to the fact that hSLBP may not interact
as well with xSLIP1 as xSLBP1 does. We also confirmed that
the expression of SLBP or SLIP1 had no effect on the stability
of the reporter RNAs in the oocytes, as found previously for
SLBP (24) (Fig. 4E). We conclude that SLIP1 together with
SLBP stimulates the translation of mRNAs ending in the his-
tone 3 stem-loop.
The translation of a luciferase reporter ending in an MS2
stem-loop is stimulated by an MS2-SLBP fusion protein both
in reticulocyte lysates (24) and in Xenopus oocytes (7). We
tested the ability of an MS2-SLIP1 fusion protein to activate
the translation of the luciferase reporter in reticulocyte lysates
by use of the approach previously described (24). Expression of
the hSLBP, hSLIP1, and MS2 fusion proteins and luciferase
reporters were visualized by SDS-PAGE and luciferase quan-
titated by luminometry assay (Fig. 4F). In unsupplemented
reticulocyte lysates, the Luc-SL and Luc-MS2 reporters were
translated at the same level, which was unaffected by the ad-
dition of MS2 protein (Fig. 4F). The addition of MS2-hSLBP
FIG. 3. SLIP1 interacts with the translation activation domain of SLBP. (A) The predicted protein sequence of the SLIP1 protein (accession
number EU287989). (B) MS2 viral coat protein (lane 1), hSLIP1 (lane 2), or hSLBP (lane 3) was synthesized by in vitro translation (IVT) in the
reticulocyte lysate. An aliquot of the lysate was resolved by gel electrophoresis together with a lysate from HeLa cells (lane 4). hSLIP1 protein was
detected by Western blotting using the antibody against the C-terminal peptide of hSLIP1. (C) Directed yeast two-hybrid assays between xSLBP1
and hSLIP1. Four independent yeast colonies containing the two-hybrid vectors were spotted on plates lacking L, W, and H in the presence of 20
mM 3-aminotriazole, and growth was observed. The wild-type (wt) xSLBP1, the W73A mutant, and a mutant with a deletion of aa 68 to 123 of
xSLBP1 were analyzed. Expression levels of wild-type and mutant xSLBP1s were assayed by Western blotting. (D) Full-length xSLBP1 and the
indicated mutant proteins were labeled with [35S]methionine by in vitro translation, GST (lanes 2, 5, 8, 11, 14, 17, 20, and 23) or GST-hSLIP1 (lanes
3, 6, 9, 12, 15, 18, 21, and 24) was added, and then the GST proteins were isolated on glutathione agarose. The bound proteins were resolved by
gel electrophoresis and detected using a PhosphorImager. Lanes 1, 4, 7, 10, 13, 16, 19, and 22 are 10% of the input used in the pulldown assays.
(E) hSLIP1 was labeled with [35S]methionine by in vitro translation and GST or the indicated GST-hSLBP fusion proteins were added and the
bound proteins were detected as described for panel D. Lane 7 is 10% of the input for each reaction. A schematic of the hSLBP showing the
translation activation domain is below the figure. (F) Recombinant His-hSLBP (lane 1) was incubated with GST (lane 2) or recombinant
GST-hSLIP1 (lane 3). The proteins bound to glutathione agarose were detected by Western blotting using anti-hSLBP. The same amount of
hSLBP (lane 1) was used in all reactions.
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activated translation to the same extent on both reporters, as
previously described (24). The addition of hSLIP1 had a small
effect on the translation of the Luc-SL reporter and no effect
on the Luc-MS2 reporter. In contrast, the addition of MS2-
hSLIP1 had the same effect as SLIP1 on the Luc-SL reporter,
and there was a much larger effect on the Luc-MS2 reporter,
similar to that of MS2-SLBP. Thus, results suggest that the
recruitment of SLIP1 to the 3 end of the mRNA is sufficient
to increase the translation of the Luc-MS2 reporter (Fig. 4F).
hSLIP1 activates the translation of histone mRNAs in mam-
malian cells. To determine whether hSLIP1 also affected the
translation of mRNAs ending in the histone stem-loop in
mammalian cells, we utilized a GFP reporter gene ending in
the histone stem-loop and quantified the expression of GFP by
FACS analysis (31). We compared the expression of the
GFP-SL gene to that of the GFP-poly(A) gene (Fig. 5A).
Transfection of hSLBP specifically stimulated expression of
the stem-loop reporter as previously reported (28). The trans-
fection of hSLIP1 also stimulated the expression of the
GFP-SL reporter but had a much smaller effect on the trans-
lation of the GFP-poly(A) reporter (Fig. 5A). The expression
of both hSLIP1 and hSLBP together resulted in a similar
increase in GFP expression as the expression of either protein
alone.
The production of substantial amounts of GFP-SL mRNA
from this reporter requires the expression of ZFP100, a U7
snRNP protein that is limiting for the expression of histone
mRNA (28). To further assess the role of SLIP1 in translation
in mammalian cells, we transfected cells with both ZFP100 and
the GFP-SL reporter. Twenty-four hours later, we transfected
cells with increasing amounts of SLIP1 and then analyzed the
levels of GFP-SL mRNA by Northern blotting and of GFP
FIG. 4. Activation of translation of reporter mRNAs ending in a histone stem-loop by SLIP1. (A) Xenopus oocytes were injected with buffer
or with capped synthetic mRNA encoding the indicated protein(s), 16 h prior to the injection of Luc-SL or Luc-TL mRNA. Results are expressed
relative to the expression of the Luc-TL mRNA. (B) An experiment similar to that described for panel A, except that the oocytes expressing the
various proteins were injected with the either the Luc-SL or Luc-poly(A) reporter as well as Luc-TL. The relative expression of Luc-SL or
Luc-poly(A) in the oocytes injected with buffer was set at 1. (C and D) Western blot analysis of the experiment whose results are shown in panel
A. (C) Western blotting of the samples with the hSLIP1 antibody raised against the complete protein. The band indicated with an asterisk is a
cross-reacting protein. (D) Shown are the same lysates analyzed with the xSLBP1 antibody (top) or the hSLBP antibody (bottom). (E) Oocytes
were injected with buffer (lane 3) or the mRNA encoding the indicated proteins (lanes 4 and 5) and then injected with 3 ng of Luc-SL RNA, and
RNA was prepared from the oocytes 16 h later. Lane 2 shows RNA from oocytes injected only with the reporter mRNA. One oocyte equivalent
of RNA was analyzed by Northern blotting for luciferase mRNA. Three nanograms of in vitro-transcribed Luc-SL mRNA was mixed with an E.
coli tRNA carrier as a control (lane 1). (F) We analyzed the effect of the indicated proteins on the translation of reporter histone mRNAs as
previously described (24). The indicated proteins were synthesized in the reticulocyte lysate. We then added fresh lysate to each reaction and
assayed the translation of uncapped Luc-SL, Luc-TL, or Luc-MS2 mRNA. The amount of luciferase activity was determined by luminometry.
The Luc-SL, Luc-TL, and Luc-MS2 RNAs in the absence of in vitro-translated SLBP or SLIP1 produced similar amounts of luciferase, which
was set at 1.
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protein by use of FACS 48 h later. Increased levels of hSLIP1
increased the expression of the GFP protein up to fivefold in a
concentration-dependent manner (Fig. 5B).
We determined whether the expression of hSLIP1 altered
the amount of total GFP mRNA or processed GFP mRNA
ending at the stem-loop. We measured the amount of GFP
mRNA processed at the histone 3 end in cells transfected with
ZFP100 24 h before the transfection of hSLIP1 (28) by use of
S1 nuclease mapping (Fig. 5C, lanes 1 to 4). There was no
change in the amount of processed reporter mRNA or of
readthrough reporter mRNA with transfection of increasing
amounts of hSLIP1. We also performed Northern blot analysis
for total GFP mRNA and 7SK RNA (as an internal control) on
the same samples (Fig. 5C, lanes 5 to 8). The expression of
hSLIP1 stimulated GFP expression but did not increase the
levels of GFP-SL mRNA in either of these assays, indicating
that the increased GFP levels are due to increased translation
of the GFP-SL mRNA. There was no change in the cell cycle
distribution after the expression of SLIP1 or SLBP in these
cells (not shown), indicating that these results are not due to an
increase in the number of S-phase cells.
SLIP1 interacts with both SLBP and eIF4G. To determine
whether SLBP and SLIP1 interact in cells, we used the anti-
hSLIP1 antibody to the C-terminal peptide, which efficiently
precipitates SLIP1 from total cell lysates from HeLa cells (Fig.
6A, top, lane 3). Western blotting of the immunoprecipitates
for SLBP revealed that anti-hSLIP1 coprecipitates hSLBP
(Fig. 6A, middle, lane 3). The addition of RNase to the lysate
prior to the immunoprecipitation only slightly reduced the
amount of SLBP that was coimmunoprecipitated (Fig. 6A,
middle, lane 5). This demonstrates that endogenous SLBP and
hSLIP1 interact in vivo and that the interaction is independent
of RNA.
Since PABP interacts with eIF4G to circularize mRNAs (8,
34), we also tested the SLIP1 immunoprecipitates for the pres-
ence of eIF4GI. eIF4GI was present in the immunoprecipi-
tates (Fig. 6A, bottom, lane 3). However, treatment of the
lysate with RNase prior to immunoprecipitation resulted in the
loss of eIF4GI from the immunoprecipitates (Fig. 6A, bottom,
lane 5).
Since the translation of polyadenylated mRNAs requires
interaction between the 5 end and the 3 end of the mRNA
mediated by PABP binding to eIF4G, we tested whether there
was a direct interaction between SLIP1 and eIF4G. We syn-
thesized eIF4GI and eIF4GII by in vitro translation and tested
the ability of GST-hSLIP1 to bind to the 35S-labeled proteins
(Fig. 6B). Both eIF4GI and eIF4GII bound to GST-hSLIP1
better than they bound to GST (Fig. 6B, lane 3). We tested
various fragments of eIF4GI and eI4GII for their abilities to
interact with GST-hSLIP1. Fragments containing approxi-
mately the first 420 aa of eIF4GI and eIF4GII each interacted
with GST-hSLIP1. The binding activity was present in aa 27 to
170 of eIF4GI (Fig. 6B, middle, lane 6), while the fragment
from 170 to 420 bound GST as well as it bound GST-hSLIP1
(Fig. 6B, bottom, lanes 5 and 6). Similarly, the binding of
hSLIP1 to eIF4GII aa 101 to 420 was weaker than the binding
to aa 31 to 420, suggesting that hSLIP1 binds within aa 31
to 101.
To determine whether the interaction could occur between
recombinant proteins, we tested the ability of His-tagged
FIG. 5. SLIP1 stimulates the translation of a histone stem-loop
reporter in mammalian cells. (A) A reporter encoding GFP followed
by the histone stem-loop and processing signals or a reporter encoding
GFP followed by a polyadenylation signal (28, 31) was transfected into
293T cells together with plasmids expressing the indicated proteins.
Forty-eight hours later, the cells were harvested and the amount of
GFP expression was quantified using FACS analysis. Average GFP
intensity for a population of cells transfected with either reporter was
normalized to the average GFP intensity of the same reporter trans-
fected into LacZ-expressing cells. (B) An experiment similar to that
described for panel A, except that the ZFP100 plasmid was transfected
into the cells together with the reporter construct to promote the
expression of the processed GFP-SL mRNA (28). The hSLIP1 plasmid
was then transfected 24 h later, the cells were harvested 48 h after the
second transfection, and the expression of GFP was quantified.
(C) (Top) Total cell RNA from the cells from panel B was analyzed
using an S1 nuclease protection assay (28) that allows detection of the
mRNAs processed at the 3 end and the mRNAs resulting from
readthrough past the 3 end (arrows). The position of the probe is
indicated. The RNAs were from cells transfected with ZFP100 (lane 1)
and with ZFP100 plus increasing amounts of SLIP1 (lanes 2 to 4).
(Bottom) Northern blotting was done on the same RNA samples to
determine the amount of GFP mRNA and 7SK snRNA present in
total cell RNA (lanes 5 to 8).
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eIF4GI to interact with GST-hSLIP1 (Fig. 6C). GST-hSLIP1
bound to recombinant eIF4GI(27-129) but not to eIF4GI(123-
420) (Fig. 6C, lanes 3 and 6). Thus, hSLIP interacts with the
N-terminal region of eIF4GI. The binding site for PABP is 172
to 200 in eIF4GI (8). Thus, the binding site for hSLIP1 on
eIF4GI is close to, but does not overlap with, the binding site
for PABP. Additionally, the 27 to 129 fragment did not bind to
recombinant SLBP (Fig. 6C, lane 9), consistent with the in-
ability of other investigators to detect a direct interaction be-
tween SLBP and eIF4G (7).
SLIP1 does not bind directly to RNA (unpublished results).
Note that SLIP1 was active both in frog oocytes and in mam-
malian cells using reporter mRNAs that lacked any histone
sequences other than the stem-loop. Thus, the likely role of
SLIP1 is to help circularize the mRNA by interacting with both
SLBP and eIF4G and not directly with the mRNA.
We also examined the effect of HU on the association of
SLIP1 with SLBP and eIF4G. The treatment of cells with HU
results in a rapid reduction in histone mRNA levels, with no
effect on SLBP levels (35). We carried out immunoprecipita-
tion experiments using cells stably expressing HA-hSLIP1. HA
antibody was used to immunoprecipitate HA-tagged hSLIP1,
and the presence of SLBP (Fig. 6D) or eIF4GI (Fig. 6E) was
probed by Western blotting. Precipitation with an anti-myc
antibody was used as a control. We detected SLBP associated
with SLIP1, and this association was not affected by HU treat-
ment (Fig. 6D, lanes 3 and 6). However, the treatment of cells
with HU resulted in the loss of SLIP1 interaction with eIF4GI
(Fig. 6E, lane 3), consistent with the loss of histone mRNA
after HU treatment.
We interpret these experiments to imply that SLIP1 is bound
to the translating histone mRNA and tethered to the 3 end of
the mRNA by SLBP and that it then interacts with eIF4GI at
the 5 end of the mRNA. The interaction between SLIP1 and
SLBP is strong enough to be maintained in the absence of
RNA. The interaction between SLIP1 and eIF4G is weaker,
and the proteins do not remain associated during immunopre-
cipitation in the absence of RNA. These results are consistent
FIG. 6. SLIP1 interacts with SLBP and eIF4G in vitro and in vivo. (A) Lysates prepared from exponentially growing HeLa cells were
immunoprecipitated with anti-myc (lanes 2 and 4) or anti-SLIP1 antibody against the C terminus of hSLIP1 (lanes 3 and 5). One-half of the lysate
was treated with RNase prior to immunoprecipitation (lanes 4 and 5). Precipitates were probed by Western blotting with antibodies against the
C terminus of hSLIP1, hSLBP, or eIF4GI. Lane 1 is 5% of the input. (B) A schematic of the structure of eIF4GI based on data from the study
of Hinton and coworkers (7a) is shown at the top. Full-length eIF4GI (lanes 1 to 3, top) or eIF4GII (lanes 1 to 3, bottom) or the indicated
fragments of eIF4GI (lanes 4 to 6) or eIF4GII (lanes 7 to 9) were labeled with [35S]methionine by in vitro translation. The lysates were incubated
with either GST (lanes 2, 5, and 8) or GST-hSLIP1 (lanes 3, 6, and 9), and the bound proteins were resolved by electrophoresis and detected by
autoradiography. Input protein (10%) was analyzed in lanes 1, 4, and 7. (C) The indicated fragments of His-tagged eIF4GI (lanes 1 to 3, 27 to 129;
lanes 4 to 6, 123 to 420) were expressed in bacteria and incubated with GST (lanes 2 and 5) or GST-hSLIP1 (lanes 3 and 6). The proteins were
recovered on GST-agarose and bound proteins detected by Western blotting for the histidine tag. The recombinant eIF4GI region from 27 to 129
was incubated with GST (lane 8) or GST-hSLBP (also His tagged; lane 9), and the proteins were recovered on GST-agarose. The bound proteins
were detected by Western blotting for the His tag. (D and E) Lysates were prepared from exponentially growing HeLa cells stably expressing
HA-tagged hSLIP1 or from cells treated with HU for 1 h. The lysates were immunoprecipitated with either anti-myc (lanes 2 and 5) or anti-HA
(lanes 3 and 6) antibodies, and bound proteins were resolved by electrophoresis and detected by Western blotting. Samples shown in panel D were
Western blotted against hSLIP1 and hSLBP. Lanes: 1 to 3, control; 4 to 6, HU treated. (E) Shown is an analysis of the same two samples Western
blotted with eIF4GI antibody. Top, control; bottom, HU treated. -, anti-.
1190 CAKMAKCI ET AL. MOL. CELL. BIOL.
with the results of Ling et al. that SLBP and eIF4G coimmu-
noprecipitate in an RNA-dependent manner (16). We note
that similar results were obtained with PABP, which also in-
teracts with eIF4G. Coimmunoprecipitation of eIF4G with
PABP from cells is also RNase sensitive, although the proteins
clearly interact in vitro (8).
SLIP1 is an essential protein in HeLa cells. To establish
whether SLIP1 is an essential gene, we used RNA interference
(RNAi) to knock down hSLIP1 in HeLa cells (Fig. 7). As a
control, we also used RNAi to knock down SLBP, which slows
progression through S phase without affecting viability (29)
(Fig. 7A). The treatment of HeLa cells with either siRNA1 or
2 against hSLIP1 resulted in a rapid depletion of hSLIP1 pro-
tein and cell death, with 50% of the cells dying within 24 h and
over 75% dying by 72 h (Fig. 7A and B). HeLa cells treated
with a control siRNA, C2 (29), were not affected. Thus, unlike
SLBP, hSLIP1 is essential for the viability of HeLa cells and
other cell lines that we tested (data not shown). Each siRNA
effectively depleted both HA-tagged hSLIP1 expressed from a
transfected gene (Fig. 7C, top, lanes 4 to 6) and the endoge-
nous hSLIP1 (Fig. 7C, middle, lanes 4 to 6), using the antibody
to the full-length SLIP1 protein. A Western blot against the
PTB protein was used as a loading control (Fig. 7C, bottom).
To demonstrate that cell death was a result of knocking
down hSLIP1, we created a gene expressing an RNAi-resistant
form of hSLIP1 mRNA (mutating the siRNA1 target site).
Expressing the RNAi-resistant form of hSLIP1 restored both
cell growth (Fig. 7B) and expression of the SLIP1 protein (Fig.
7D, lane 8) in cells treated with siRNA1 but not siRNA2,
confirming that the cell death phenotype was due to SLIP1
depletion. There was no change in cell cycle distribution in the
HeLa cells as a result of the knockdown of SLIP1 (Fig. 7E).
Cell death was likely due to apoptosis, based on the loss of
full-length caspase 9 (data not shown), and the accumulation
of cells containing less than 2 N DNA content (data not
shown). While the biological lesion in the cell that results in the
activation of the apoptotic pathway is not known, knocking
down SLBP, which has a larger effect on histone protein bio-
FIG. 7. Knockdown of SLIP1 results in the death of HeLa cells. (A) Cells were transfected with two different siRNAs against SLIP1 (siRNA1,
closed triangles; siRNA2, closed squares; siRNA 1 and 2 together, stars), a siRNA against SLBP (open diamonds), and a control siRNA (closed
circles). Cell viability was assessed by trypan blue staining at the indicated times posttransfection. (B) Cells were transfected with siRNA1 against
hSLIP1 or a control siRNA, together with either a plasmid expressing GFP (SLIP1 siRNA, closed triangles; control siRNA, closed circles) or a
plasmid expressing an RNAi-resistant SLIP1 (SLIP1 siRNA, open triangles; control siRNA, open circles) constructed by mutating the third
nucleotides of the codons in the region targeted by the siRNA. The viability of the cells was determined daily for 3 days. There were also fewer
total cells in the siRNA-treated cultures without the RNAi-resistant SLIP1, suggesting that cell growth had also been affected and that dead cells
that had lysed were no longer detectable. (C) Western blots were used to assess the abilities of the two different siRNAs to knock down endogenous
SLIP1 protein and exogenously expressed SLIP1 (HA-tagged SLIP1) in HeLa cells (lanes 4 and 5) and a combination of the two SLIP1 siRNAs
(lane 6). Cells were also transfected with a control siRNA C2 (lane 2) or a siRNA against SLBP (lane 3). Cell lysates were prepared, and equal
amounts of protein resolved by gel electrophoresis were analyzed by Western blotting using an anti-HA antibody (top), the hSLIP1 antibody to
the full-length protein (middle), or an antibody against PTB (30) as a loading control (bottom). (D) Cells were treated with either the control
siRNA (lanes 2 to 4) or the indicated SLIP1 siRNA (lanes 5 to 8) together with either a plasmid expressing HA-tagged SLIP1 (lanes 3 and 6) or
a plasmid expressing HA-SLIP1 resistant to siRNA1 but not siRNA2 (lanes 4, 7, and 8), and lysates were analyzed by Western blotting using
anti-hSLIP1 antibody. (E) Cells treated with siRNAs against control (C2), SLBP, or SLIP1 as described above. Cells were harvested, stained with
propidium iodide, and analyzed by FACS to determine cell cycle profiles.
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synthesis (Fig. 8), does not result in cell death, suggesting that
there may be another pathway for which SLIP1 is essential.
We also assessed the effect of SLIP1 depletion on endoge-
nous histone mRNA levels and histone protein synthesis. For
these experiments, we knocked down SLIP1 in HeLa cells for
the minimal time that gave substantial knockdown (about
70%) (Fig. 8A, top, lane 6) but retained cell viability. There
was only a small decrease in SLBP protein levels in the SLIP1
knockdown cells (Fig. 8A, middle, lane 6). We used the anti-
body against the C terminus of hSLIP1 for these analyses. We
also knocked down SLBP in a parallel culture of cells and
carried out the same analysis. The SLBP knockdown was about
75% effective (Fig. 8A, middle, lane 7) and there was no
change in SLIP1 levels in the SLBP knockdown cells (Fig. 8A,
top, lane 7). A cross-reacting band is shown as a loading con-
trol (Fig. 8A, bottom).
We analyzed the levels of histone mRNA in these cells
relative to the level of 7SK RNA, and there was not a signif-
icant change in histone mRNA levels in either SLBP knock-
down or SLIP1 knockdown cells (Fig. 8B), consistent with
there being no change in cell cycle distribution. A reduction of
histone mRNA levels due to SLBP knockdown requires longer
treatment with siRNA and a more complete knockdown of
SLBP (E. J. Wagner and W. F. Marzluff, unpublished data).
To assess the rate of histone protein synthesis, we starved
the siRNA-treated cells for methionine for 30 min, labeled the
cells for 10 min with [35S]methionine, and resolved total nu-
clear proteins by SDS-PAGE. We also analyzed the cytoplasm
of these same cells, and there was no newly synthesized histone
protein in this fraction (not shown). We consistently saw higher
levels of total methionine incorporation in the SLIP1 knock-
down cells for unknown reasons and thus performed analyses
loading either equal amounts of radioactive protein (Fig. 8C
and D, lanes 1 and 2) or equal amounts of total protein (Fig.
8C and D, lanes 3 to 5). We quantified the amount of radio-
labeled H2a/H3 histone using a PhosphorImager and com-
pared the levels of the histone proteins to two prominent
labeled bands of nonhistone protein (Fig. 8D). There was no
change in the relative intensity of the nonhistone protein
bands, as judged either by Coomassie staining (Fig. 8C) or by
autoradiography (Fig. 8D). In the SLBP knockdown, there was
a decrease of 50% in histone protein synthesis, consistent with
a role for SLBP in translation. There was reproducibly a 20 to
30% decrease in histone protein synthesis when SLIP1 was
knocked down. The ratio of the two control bands varied by
only 5% among the various samples.
These experiments, together with the stimulation of the
translation of the histone reporter mRNA (Fig. 5), demon-
strate a role for SLIP1 in the translation of mRNAs ending in
the histone stem-loop in mammalian cells. The modest effect
on translation in the SLBP and SLIP1 knockdown cells is likely
due to the residual proteins present in the cells. Because SLIP1
depletion results in cell death while SLBP depletion does not,
our data suggest that SLIP1 may function in other important
cellular processes in addition to histone mRNA translation.
DISCUSSION
All known eukaryotic cellular mRNAs, with the exception of
the metazoan replication-dependent histone mRNAs, are poly-
adenylated. Efficient translation of polyadenylated mRNAs re-
quires both the 5 cap and 3 poly(A) tail of the mRNAs. The cap
at the 5 end is bound by eIF4E and the poly(A) tail at the 3 end
is bound by PABP. These two proteins bind to eIF4G, allowing
eIF4G to bind and recruit eIF3 and the small ribosomal subunit,
resulting in the initiation of translation.
While all eukaryotic mRNAs, including the metazoan repli-
cation-dependent histone mRNAs, require the 5 cap and 3
end for efficient translation, some viral RNAs utilize a special-
FIG. 8. Effect of SLIP1 and SLBP knockdown on histone protein
synthesis. (A) HeLa cells were treated with siRNA for SLIP1 or SLBP
for 4 days. Western blots (top, anti-SLIP1; middle, anti-SLBP; bottom,
loading control) were done to assess the knockdown of each protein.
C2 is a control siRNA, and the loading control is a cross-reacting band
with the hSLIP1 antibody. Lanes 1 to 4 are serial dilutions of the
C2-treated lysate. Lanes 5 to 7 are extracts of cells treated with C2
siRNA, SLIP1 siRNA, and SLBP siRNA, respectively. (B) The levels
of histone mRNA and 7SK RNA were determined by Northern blot-
ting from the cells from panel A. (C) The total nuclear protein from
the cells from panel A was resolved by electrophoresis on 15% SDS-
polyacrylamide gels and stained with Coomassie blue. The histone
proteins are indicated. (D) The gels from panel C were dried and
autoradiographed. The H2a/H3 histones were quantified on a
PhosphorImager, as were the two bands indicated by arrows. The ratio
of the two nonhistone bands indicated by arrows to each other was
constant (	5%), and the levels of histone protein synthesis are indi-
cated. -, anti-.
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ized 3 end for translation. The rotavirus genome mRNA does
not end in a poly(A) tail and is translated in mammalian cells.
Its translation is mediated by the viral protein NSP3, which
binds both to the 3 end of viral mRNA and to the same region
on eIF4G as PABP binds. NSP3 may circularize the viral RNA
(21, 27), although this role for NSP3 has recently been ques-
tioned (19). Many viral mRNAs which infect plants are also
not polyadenylated, ending instead in a complex RNA
pseudoknot (15). The 3 ends of these mRNAs are also re-
quired for their translation, and some of these viruses (e.g., the
alfalfa mosaic virus) encode proteins that bind to the 3 end of
their mRNA and eIF4G (14, 20).
SLIP1 binds SLBP and stimulates histone mRNA transla-
tion. The 3 end of histone mRNA is required for the efficient
translation of histone mRNA both in mammalian cells (6) and
in Xenopus oocytes (24). SLBP stimulates the translation of
reporter mRNAs ending in the histone 3 end both in Xenopus
oocytes and in a rabbit reticulocyte lysate (24). We identified a
15-aa region in SLBP essential for translation that includes a
highly conserved motif, DWX3VEE, and identified a novel
protein, SLIP1, that interacts with this sequence. Point muta-
tions in the conserved core translation region of SLBP prevent
the activation of translation of a reporter ending in a histone
stem-loop (Fig. 2) and also inhibit the binding of SLBP to
SLIP1 (Fig. 3), strongly supporting a role for SLIP1 in histone
mRNA translation.
SLIP1 is a 25.4-kDa protein that has putative orthologues in
all metazoans but no obvious orthologue in plants or fungi.
Plants and fungi express polyadenylated histone mRNAs and
thus would not require SLIP1 for histone mRNA translation.
The crystal structure of the Danio rerio orthologue indicates
that SLIP1 consists of multiple HEAT domains and is similar
to the middle domain of eIF4G in this respect (17). SLIP1 is
not cell cycle regulated and is present in both the nucleus and
the cytoplasm, as judged by immunofluorescence of HA-SLIP1
with anti-HA antibodies as well as measurement of endoge-
nous SLIP1 by Western blotting after cell fractionation (R. S.
Lerner and W. F. Marzluff, unpublished data).
SLIP1 stimulates the translation of a reporter mRNA ending
in a stem-loop when it is expressed together with SLBP in
Xenopus oocytes, although the expression of hSLIP1 has little
effect on the translation of the reporter RNA when only en-
dogenous levels of xSLBP1 and xSLIP1 are present in Xenopus
oocytes (Fig. 4A). SLIP1 also stimulates the translation of a
reporter mRNA ending in a stem-loop in mammalian cells but
has little effect on the translation of a polyadenylated reporter
mRNA in either Xenopus oocytes or mammalian cells, dem-
onstrating that it does not affect the translation of all mRNAs
(Fig. 4 and 5). hSLBP has lower activity than xSLBP1 in oo-
cytes, suggesting that it does not interact optimally with the
Xenopus translation factors, such as xSLIP1 (24) (Fig. 4A).
However, the expression of hSLIP1 together with hSLBP re-
sulted in maximal activation of the reporter (Fig. 4A). Impor-
tantly, there was no change in the levels of the reporter
mRNAs in either oocytes or mammalian cells after SLIP1
expression (Fig. 4E and 5C), while there was increased expres-
sion of reporter protein, consistent with a role of SLIP1 in
translation.
SLIP1 interacts with eIF4G, bridging the 3 and 5 ends of
the mRNA. Previously, Ling and coworkers showed that eIF4G
could be coimmunoprecipitated from cell lysates with SLBP,
although this interaction was RNase sensitive (16). No direct
interaction between SLBP and eIF4G has been detected de-
spite extensive efforts (7). Our results strongly suggest that
SLIP1 provides the bridge between SLBP and eIF4G, bridging
the 5 and 3 ends of the mRNAs. SLIP1 interacts with the
amino-terminal portion of eIF4GI and eIF4GII, in the same
general region as PABP binds, although the binding sites are
distinct, since SLIP1 interacts with a fragment of eIF4G that
does not contain the PABP binding site (Fig. 6B and C). While
SLIP1 clearly interacts with eIF4G, it is possible that it also
contacts other components of the translation initiation ma-
chinery.
SLIP1 is an essential protein in cultured mammalian cells.
Knocking down hSLIP1 in HeLa cells (Fig. 7) by RNAi results
in rapid cell death. This phenotype is a result of the hSLIP1
knockdown, since the expression of an RNAi-resistant hSLIP1
rescues cell viability. This phenotype was unexpected, since
knocking down other proteins required for histone mRNA
metabolism, such as SLBP (29, 37), ZFP100, Lsm10, or Lsm11
(28), does not affect cell viability but rather causes cell cycle
arrest. hSLIP1 is not cell cycle regulated (Lerner and Marzluff,
unpublished) and is also present in reticulocytes which do not
contain nuclei. These results suggest that SLIP1 likely has
other function(s) in addition to participating in histone mRNA
translation.
Mechanism of histone mRNA translation. The efficient
translation of polyadenylated mRNAs requires that both
PABP and eIF4E bind to the 3 and 5 ends of the mRNA,
respectively, and each of these proteins then binds to eIF4G to
circularize the mRNA. It is likely that the 3 end of the histone
mRNA interacts with the 5 end of the mRNP, since there is a
requirement for both the cap and the 3 end for translation in
vivo in mammalian cells (6). These results strongly suggest that
SLIP1 is a critical factor in histone mRNA translation. SLBP
does not interact directly with eIF4G, but the data presented
here suggest that SLIP1 binds to both SLBP and eIF4G and
allows circularization of histone mRNAs (7). It is likely that
the mechanisms of translation of polyadenylated mRNAs and
histone mRNAs are similar, and it is possible that the role of
SLIP1 is to help bring the 5 end and the 3 end of histone
mRNAs together to facilitate translation initiation.
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